RxDoctor Payments Data

Starsha Ford

Psychiatric/Mental Health · Little Rock, ARNPI 1649907593

Payments from drug & device makers

$486in general payments, 2019–2025

Across 25 payments — averaging $19.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$193
  • Takeda Pharmaceuticals U.S.A., Inc.$126
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$45
  • Johnson & Johnson$39
  • Vanda Pharmaceuticals Inc.$19
  • Neurocrine Biosciences, Inc.$19
  • plus $46 from 3 others

What the payments were for

  • Food & beverage$486100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$486 in reported general payments places this provider in the 35th percentile of 359 psychiatric/mental health providers in Arkansas.

See all psychiatric/mental health providers in Arkansas

Medicare billing

Part B allowed, 2024
$23,578
Medicare patients
44
Services billed
307

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
SpravatoEsketamine Hcl22$26,310
VraylarCariprazine Hcl11$16,885
TrintellixVortioxetine Hydrobromide20$9,951
Aripiprazole124$2,380
Olanzapine41$2,023
Divalproex Sodium ErDivalproex Sodium18$1,628
Atomoxetine Hcl18$1,308
Quetiapine Fumarate89$1,198
Hydroxyzine Hcl68$984
Ziprasidone Hcl28$958
Hydroxyzine Pamoate34$755
Duloxetine Hcl58$681
Buspirone Hcl66$666
Bupropion XlBupropion Hcl39$633
Venlafaxine Hcl ErVenlafaxine Hcl60$618

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonSpravato$39$26,31022 claims
AbbVieVraylar$193$16,88511 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$126$9,95120 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 359 psychiatric/mental health providers in Arkansas.

Other psychiatric/mental health in Little Rock

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →